Skip to main content
. 2021 Nov 26;11:768035. doi: 10.3389/fonc.2021.768035

Table 2.

Adverse events and costs in the pembrolizumab group and chemotherapy group.

Medical cost ($) Pembrolizumab group Grade 3-5 (%) Placebo group Grade 3-5 (%) Reference
Nausea 14.62 3.5 4 (15)
Anemia 604.03 18.3 15.8 (16)
Fatigue 135.51 6.9 3.5 (15)
Diarrhea 5.90 5.2 3 (16)
Neutropenia 541.85 16 12.4 (15)
Vomiting 14.62 4 3 (15)
Dyspnea 343.18 4.2 5 (17)
Asthenia 135.51 6.7 3.5 (15)
Thrombocytopenia 550.91 8.4 6.9 (16)